Padagis Starts Life Post-Perrigo With Eucrisa Challenge
12 Oct 2021 //
PHARMAINTELLIGENCE
Padagis Confirms First-to-File Patent Challenge For Generic Version Of Eucrisa®
28 Sep 2021 //
PRNEWSWIRE
Pfizer Europe Generic Staquis(Crisaborole) Receives Approval In Europe
22 Apr 2020 //
EMA
U.S. FDA Approves Supplemental sNDA for Expanded Indication of EUCRISA®
24 Mar 2020 //
BUSINESSWIRE
Givlaari, Nubeqa among Jan CHMP decisions
03 Feb 2020 //
PHARMATIMES
Hey, big spender: Pharma`s $6.6B TV ad outlay outranks most other industries
16 May 2019 //
FIERCE PHARMA
Novartis orchestrates $1.1B deal for a MorphoSys/Galapagos eczema drug
20 Jul 2018 //
ENDPTS
Growth of Sanofi-Regeneron`s Dupixent in Atopic Dermatitis First Plateau
02 Feb 2018 //
PR NEWSWIRE
Pfizer rolls Eucrisa campaign as Dupixent heats up eczema market
23 Aug 2017 //
FIERCE PHARMA